secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001420720-24-000015
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio raises ~$15.1M in PIPE at $2.85/unit (148% premium), extends cash runway through FY2025
--------------------------------------------------------------------------------

- Gross proceeds of ~$15.1M from common shares, pre-funded warrants, and Series E warrants at $2.85 per unit.
- Net proceeds of ~$14.1M; intended for R&D and working capital, extending cash runway through fiscal 2025.
- Series E warrants exercisable after 6 months at $2.64/share for 5 years; $2.85 price represents 148% premium to last close.
- Amended credit agreement with Woodforest National Bank, extending term loan maturity to May 15, 2024.
- Q3 FY2024 saw exercise of 1,131,500 Class C and 1,006,500 Class D warrants; shares outstanding now 8,515,226.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000015/0001420720-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000015/ibio-20240326x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer